Biotechnology - Mergers & Acquisitions, Biosimilars

Filter

Popular Filters

Carved up ownership of Russia’s Biocad planned by Pharmstandard and Millhouse

Carved up ownership of Russia’s Biocad planned by Pharmstandard and Millhouse

23-05-2014

Russia’s largest pharma company Pharmstandard and Millhouse, an investment company owned by Russian…

BiocadBiosimilarsBiotechnologyBusiness FinanceChief executiveDrugsMergers & AcquisitionsPharmacologyPharmstandardRoman AmbromovichRussia

Epirus to acquire Zalicus, creating a publicly-traded biosimilars enterprise

16-04-2014

Boston-based privately-held Epirus Biopharmaceuticals, focused on the global development and commercialization…

BiosimilarsBiotechnologyEPIRUS BiopharmaceuticalsMergers & AcquisitionsZalicus

Walvax Biotech to take 64% stake in Genor BioPharma for around $49 million

Walvax Biotech to take 64% stake in Genor BioPharma for around $49 million

31-12-2013

China’s Walvax Biotech has revealed it plans to acquire a controlling 64% equity stake in Shanghai’s…

Asia-PacificBiosimilarsBiotechnologyChinaMergers & AcquisitionsOncology

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top